IFM Investors Pty Ltd Has $11.45 Million Stock Position in MetLife, Inc. (NYSE:MET)

IFM Investors Pty Ltd cut its holdings in shares of MetLife, Inc. (NYSE:MET) by 0.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 138,765 shares of the financial services provider’s stock after selling 336 shares during the period. IFM Investors Pty Ltd’s holdings in MetLife were worth $11,445,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of MET. GoalVest Advisory LLC grew its position in shares of MetLife by 73.3% in the 1st quarter. GoalVest Advisory LLC now owns 390 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 165 shares during the period. Wolff Wiese Magana LLC increased its position in shares of MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after acquiring an additional 277 shares in the last quarter. Bank & Trust Co acquired a new stake in shares of MetLife during the second quarter worth $39,000. Crewe Advisors LLC lifted its position in MetLife by 602.5% in the 2nd quarter. Crewe Advisors LLC now owns 562 shares of the financial services provider’s stock valued at $39,000 after acquiring an additional 482 shares in the last quarter. Finally, Larson Financial Group LLC boosted its stake in MetLife by 72.6% in the 2nd quarter. Larson Financial Group LLC now owns 568 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 239 shares during the period. 89.81% of the stock is currently owned by institutional investors.

MetLife Stock Performance

Shares of NYSE MET opened at $84.36 on Friday. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.56. The company has a market capitalization of $59.99 billion, a P/E ratio of 28.99, a P/E/G ratio of 0.69 and a beta of 1.04. MetLife, Inc. has a 12 month low of $57.91 and a 12 month high of $86.94. The stock has a 50 day moving average of $79.37 and a 200-day moving average of $74.36.

MetLife (NYSE:MET) last released its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $2.28 EPS for the quarter, topping analysts’ consensus estimates of $2.13 by $0.15. The firm had revenue of $17.82 billion during the quarter, compared to analysts’ expectations of $18.57 billion. MetLife had a net margin of 4.23% and a return on equity of 21.41%. The company’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same period in the previous year, the business posted $1.94 earnings per share. As a group, equities research analysts predict that MetLife, Inc. will post 8.61 EPS for the current year.

MetLife Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be paid a $0.545 dividend. The ex-dividend date of this dividend is Tuesday, November 5th. This represents a $2.18 dividend on an annualized basis and a yield of 2.58%. MetLife’s dividend payout ratio (DPR) is currently 74.91%.

Analysts Set New Price Targets

Several analysts have issued reports on MET shares. Wells Fargo & Company lifted their price target on MetLife from $86.00 to $92.00 and gave the company an “overweight” rating in a research note on Thursday, October 10th. Citigroup boosted their target price on MetLife from $83.00 to $89.00 and gave the company a “buy” rating in a research note on Tuesday, July 23rd. JPMorgan Chase & Co. raised their price target on shares of MetLife from $81.00 to $86.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 2nd. StockNews.com lowered shares of MetLife from a “buy” rating to a “hold” rating in a research report on Friday, October 4th. Finally, TD Cowen assumed coverage on shares of MetLife in a research report on Wednesday, October 9th. They issued a “buy” rating and a $97.00 target price for the company. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $88.46.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.